Mainstay Medical International

Equities

MSTY

IE00BJYS1G50

Advanced Medical Equipment & Technology

Real-time Euronext Paris Other stock markets			5-day change	1st Jan Change
- ^EUR	-.--%		-10.55%	-42.65%

03-12	Mainstay Medical Holdings plc Announces Publication of Clinical Results Comparing Older Patients and Younger Patients	CI
02-26	Mainstay Medical Holdings plc announced that it has received ?115 million in funding from a group of investors	CI

Mainstay Medical International plc Reports Earnings Results for the Full Year Ended December 31, 2018

April 18, 2019 at 12:20 pm

Mainstay Medical International plc announced earnings results for the full year ended December 31, 2018. For the full year, the company announced sales was USD 663,000 compared to USD 348,000 a year ago. Operating loss was USD 29.285 million compared to USD 27.719 million a year ago. Net loss was USD 31.077 million compared to USD 29.835 million a year ago.

Latest news about Mainstay Medical International

Mainstay Medical Holdings plc Announces Publication of Clinical Results Comparing Older Patients and Younger Patients	03-12	CI
Mainstay Medical Holdings plc announced that it has received ?115 million in funding from a group of investors	02-25	CI
Mainstay Medical Holdings plc announced that it expects to receive funding	02-22	CI
Mainstay Medical Announces Receipt of FDA Approval for MRI Labeling on Reactiv8® Restorative Neurostimulation Systemtm	02-12	CI
Mainstay Medical Announces Completion of Enrollment of RESTORE Clinical Trial of ReActiv8® in the United States	23-08-29	CI
Mainstay Medical Holdings plc Announces Publication of Three-Year Clinical Trial Data from Post-Market Clinical Follow-Up Registry of Reactiv8 in the United Kingdom	23-07-20	CI
Mainstay Medical Holdings plc Reports Earnings Results for the Full Year Ended December 31, 2022	23-03-27	CI
Mainstay Medical Holdings plc Announces the Publication of Effect of Restorative Neurostimulation on Major Drivers of Chronic Low Back Pain Economic Impact	23-03-02	CI
Mainstay Medical Announces Publication of Post-Market Clinical Trial Data from Ongoing ReActiv8®-C Study in Chronic Low Back Pain Patients	22-11-22	CI
Mainstay Medical Holdings plc Reports Earnings Results for the Full Year Ended December 31, 2021	22-03-28	CI
Mainstay Medical Holdings plc Announces Publication of Two-Year Patient Outcomes Data from Reactiv8-B Clinical Trial Demonstrating Long-Term Efficacy of Reactiv8 Restorative Neurostimulation	22-01-06	CI
Mainstay Medical Holdings plc Announces Appointment of Jeffrey Dunn and Eric Major to Its Board of Directors	21-12-14	CI
Mainstay Medical Holdings plc Reports Earnings Results for the Full Year Ended December 31, 2020	21-07-09	CI
Mainstay Medical Announces Limited Announces Commercial Launch of ReActiv8® in US	21-06-29	CI
Oxford Finance LLC Announces Closing of $50 Million Senior Secured Term Loan with Mainstay Medical Holdings plc	21-04-20	CI
Mainstay Medical Announces Commercial Launch of ReActiv8® in Australia	21-03-08	CI
Mainstay Medical Holdings plc announced that it has received $108 million in funding from Ally Bridge Group, KCK Group, Sofinnova Partners SAS, Fountain Healthcare Partners, and another investor	21-02-15	CI
Mainstay Medical Holdings plc announced a financing transaction	21-02-08	CI
Mainstay Medical Holdings plc Announces U.S. FDA Approval of ReActiv8® Neurostimulation System for Chronic Low Back Pain	20-06-22	CI
Mainstay Medical International plc Reports Earnings Results for the Full Year Ended December 31, 2019	20-02-25	CI
Mainstay Medical Announces Completion of Day 100 Meeting with FDA Regarding Pre-Market Approval Application for ReActiv8	19-12-11	CI
Mainstay Medical Announces Regulatory Approval from Australian Therapeutic Goods Administration for ReActiv8	19-12-06	CI
Mainstay Medical Announces Acceptance For Filing by US FDA Of Pre-Market Approval Application for ReActiv8	19-10-01	CI
Transcript : Mainstay Medical International plc, H1 2019 Earnings Call, Sep 20, 2019	19-09-20
Mainstay Medical International plc Reports Earnings Results for the Half Year Ended June 30, 2019	19-09-20	CI

Chart Mainstay Medical International

Duration

Period

More charts

Company Profile

Mainstay Medical International Ltd is an Ireland-based company. The Company is engaged in electromedical materials support services.

Sector

Advanced Medical Equipment & Technology

More about the company

Income Statement Evolution

More financial data

Sector Other Advanced Medical Equipment & Technology

	1st Jan change	Capi.
MAINSTAY MEDICAL INTERNATIONAL	-42.65%	29.84M
THERMO FISHER SCIENTIFIC	+10.92%	226B
DANAHER CORPORATION	+14.83%	198B
INTUITIVE SURGICAL, INC.	+19.88%	142B
BOSTON SCIENTIFIC CORPORATION	+30.51%	111B
SIEMENS HEALTHINEERS AG	+2.09%	65.26B
EDWARDS LIFESCIENCES CORPORATION	+16.49%	54.36B
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.	+4.96%	50.94B
AGILENT TECHNOLOGIES, INC.	+9.56%	44.8B
GE HEALTHCARE TECHNOLOGIES INC.	+4.40%	36.8B

Other Advanced Medical Equipment & Technology